CLINICAL_TRIALS
trial_result
· 2017-04-28
Clinical Trial Update: Study Utilizing Rilonacept in Gout Exacerbations [Phase 3]
Summary
A Phase 3 trial evaluating rilonacept for acute gout flares has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Acute Gout Flare | Phase 3 | Status: COMPLETED | Results posted: 2017-04-28